Background During the last six decades, extensive use of antibiotics has selected resistant
strains, increasing the rate of fatal infectious diseases, and exerting an economic burden on …

Klebsiella pneumoniae colonizes mucosal surfaces of healthy humans and is responsible
for one third of all Gram-negative infections in hospitalized patients. K. pneumoniae is …

Background Carbapenem resistance is epidemic worldwide, these last resort antimicrobials
are listed in the WHO 'watch group'with higher resistance potential. During the years 2017 …

Plasmid-mediated colistin resistance (Col-R) conferred by mcr genes endangers the last
therapeutic option for multifarious β-lactamase-producing bacteria. The current study aimed …

Sulbactam, a class A β-lactamase inhibitor, added to cefoperazone either at a fixed 8 mg/L
level of sulbactam or at a level of fixed cefoperazone: sulbactam ratio (2: 1) would constitute …

Background The global emergence of plasmid-mediated colistin resistance (Col-R)
conferred by mcr genes in gram-negative rods (GNRs) has jeopardized the last treatment …

Emerging extensively drug-resistant (XDR) Klebsiella pneumoniae due to the production of
β-lactamases and porin loss is a substantial worldwide concern. This study aimed to …

This study aimed to find out the prevalence and antimicrobial resistance profile of Klebsiella
pneumoniae in raw food items. A total of 261 raw food items, including vegetables, fruits …

Klebsiella pneumoniae causes severe human diseases, but its resistance to current
antibiotics is increasing. Therefore, new antibiotics to eradicate K. pneumoniae are urgently …

Background: In Gram-negative bacteria, including Klebsiellapneumoniae, the production of
AmpC beta-lactamase enzymes is one of the main resistance mechanisms for beta-lactam …